Literature DB >> 11716987

Enhancement of phospholipase D activity by overexpression of amyloid precursor protein in P19 mouse embryonic carcinoma cells.

M J Lee1, J Y Oh, H T Park, D J Uhlinger, J Y Kwak.   

Abstract

It has been shown that phospholipase D (PLD) activity is stimulated by the beta-amyloid protein in neuronal cells. The aim of this study was to determine whether overexpression of the amyloid precursor protein (APP) affects the activity and the level of PLD expression in P19 embryonic carcinoma cells. We observed that the unstimulated basal PLD activity was higher in wild-type APP(695)-transfected cells than in non-transfected control cells. The protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate (PMA), has been shown to activate PLD. PMA-stimulated PLD activity was 3-fold higher in the APP overexpressing cells than in the control cells. P19 cells express two distinct PLD isozymes, PLD1 and PLD2. The level of PLD2 expression was increased by APP overexpression. Although the PKC inhibitor, GF109203X, inhibited PMA-stimulated PLD activity, it did not affect the high basal PLD activity induced by APP overexpression. Neuronal differentiation of the P19 cells by retinoic acid did not affect the basal or PMA stimulated-PLD activity. Interestingly, APP overexpression in the differentiated P19 cells also led to an increase in PLD activity. The PLD activity of the P19 cells is apparently regulated by amyloid protein through both PKC-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716987     DOI: 10.1016/s0304-3940(01)02339-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimer's amyloid precursor protein signalling.

Authors:  Tarek Kashour; Teralee Burton; Alexander Dibrov; Francis M Amara
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Proteins that bind to the RERMS region of beta amyloid precursor protein.

Authors:  Monika Pawlik; Deborah A C Otero; Minkyu Park; Wolfgang H Fischer; Efrat Levy; Tsunao Saitoh
Journal:  Biochem Biophys Res Commun       Date:  2007-02-20       Impact factor: 3.575

Review 3.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

4.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

Review 5.  Phospholipase D in brain function and Alzheimer's disease.

Authors:  Tiago Gil Oliveira; Gilbert Di Paolo
Journal:  Biochim Biophys Acta       Date:  2010-04-23

6.  PLD3 is accumulated on neuritic plaques in Alzheimer's disease brains.

Authors:  Jun-Ichi Satoh; Yoshihiro Kino; Yoji Yamamoto; Natsuki Kawana; Tsuyoshi Ishida; Yuko Saito; Kunimasa Arima
Journal:  Alzheimers Res Ther       Date:  2014-11-02       Impact factor: 6.982

Review 7.  Lipids and Alzheimer's Disease.

Authors:  Yu-Chia Kao; Pei-Chuan Ho; Yuan-Kun Tu; I-Ming Jou; Kuen-Jer Tsai
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

Review 8.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.